Skip to main content

Fragile X Syndrome

From Genetics to Targeted Treatment

  • 1st Edition - May 26, 2017
  • Latest edition
  • Editors: Rob Willemsen, Frank Kooy
  • Language: English

Fragile X Syndrome: From Genetics to Targeted Treatment provides a structured overview of the molecular and clinical background of the disorder as well as treatment options.… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

Fragile X Syndrome: From Genetics to Targeted Treatment provides a structured overview of the molecular and clinical background of the disorder as well as treatment options. The book discusses the detailed molecular information on each of the pathways involved with sufficient details for all whose research touches this pathway. It provides a state-of-the-art update on all clinical aspects associated with this syndrome, including phenotype, diagnostics and epidemiology.

It also includes an overview of the lessons learned from the preclinical research and pioneering trials on the fragile X syndrome for the investigators involved in clinical trials of neurodevelopmental disorders. This book is written for academic researchers, pharmaceutical investigators, and clinicians in the field who work on the disorder, and for researchers involved in clinical trials of the fragile X syndrome or related disorders.

“This fascinating book, edited by Rob Willemsen and Frank Kooy, summarizes the current knowledge of the molecular aspects of fragile X syndrome (FXS), andthe potential for therapies resulting from this knowledge...Particularly interesting is a review “fragile X research from a parental perspective,” which summarizes the results of an international survey of the attitudes of families with FXS relatives towards research…This book is also an essential reference book for genetic counselors...The book provides counselors with the necessary biological background for proper explanations to the relatives of FXS patients. Many parents acquire a substantial knowledge of the conditions afflicting their children. The book will be helpful for both families and counselors to manage the expectations of families participating in clinical trials…In conclusion, this book is essential for everyone who is involved in the diagnosis and treatment of FXS patients.” - European Journal of Human Genetics (September 2018)

Key features

  • Provides a comprehensive overview of the molecular genetics, clinical trials, and treatment of Fragile X Syndrome
  • Written for academic researchers, pharmaceutical investigators, and clinicians in the field
  • Edited by international leaders in the field who have contributed greatly to the study of Fragile X Syndrome
  • Directs the reader through complex issues surrounding FXS and draws the literature together for researchers and clinicians

Readership

Researchers and clinical practitioners in neuroscience, neurology, pharmacology, genetics and genetic counseling

Table of contents

Clinics, diagnosis, epidemiology, molecular mechanisms and models

1. The Clinical Phenotype of the Fragile X Syndrome and Related Disorders

2. Fragile X Syndrome Genetics

3. Molecular Diagnostics and Genetic Counseling in Fragile X syndrome and FMR1 associated disorders

4. Epidemiology of Fragile X Syndrome

5. Mechanisms of repeat instability in Fragile X Syndrome

6. Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells

7. Animal models - drosophila, mouse, rat and zebrafish

Pathways Involved

8. RNA and protein targets of FMRP

9. The mGluR Theory of Fragile X from Mice to Men

10. The GABAergic System contributions to the Fragile X Syndrome Phenotype

11. Intracellular Signaling Networks in Fragile X Syndrome: Approaches to Drug Discovery and Therapeutics

12. The Endocannabinoid System in Fragile X Syndrome

13. Glycogen synthase kinase-3: Abnormalities and therapeutic potential in Fragile X syndrome

14. Defects in Rho GTPase signaling to the spine actin cytoskeleton in FMR1 knockout mice

15. Matrix Metalloproteinases in Fragile X Syndrome

16. Ion channel dysfunction and FXS

17. Reactivation of FMR1 gene

Clinical trials

18. Drug discovery for targeted pharmacotherapy of Fragile X Syndrome

19. Overview of targeted double blind, placebo controlled clinical trials in Fragile X Syndrome

20. Reflections on Clinical trials in Fragile X syndrome

21. Toward better outcome measures in clinical trials

22. Fragile X Research from a Parental Perspective

Product details

  • Edition: 1
  • Latest edition
  • Published: May 26, 2017
  • Language: English

About the editors

RW

Rob Willemsen

Dr. Willemsen is a Professor for Functional Neurogenetics in the Department of Clinical Genetics at Erasmus University Medical Center in Rotterdam, the Netherlands. He is a leader in the development and characterization of genetic animal models for FXS (mouse and zebrafish). His research group has been involved in the understanding of the molecular basis of FXS and currently his group is focused on experimental approaches towards therapeutic intervention for FXS. The first avenue of research has resulted in several knockout mice for the Fmr1 gene, including conditional knockout, that are now used worldwide as the standard in (pre-clinical and fundamental research) studies for FXS.
Affiliations and expertise
Department of Clinical Neurogenetics, Erasmus University Medical Center, Rotterdam, The Netherlands

FK

Frank Kooy

Dr. Frank Kooy is Professor in Cognitive Genetics at Department of Medical Genetics of the University of Antwerp. His research successfully focusses on the identification of genetic causes of cognitive disorders, such as intellectual disability and autism and to study the defective genes with the ultimate goal of developing rational therapies. He has been involved in research on multiple aspects of the Fragile X Syndrome research for two decades.
Affiliations and expertise
Department of Medical Genetics, University of Antwerp, Antwerp, Belgium

View book on ScienceDirect

Read Fragile X Syndrome on ScienceDirect